We are live on ! Find out more
CODX icon

Co-Diagnostics

95 hedge funds and large institutions have $85.8M invested in Co-Diagnostics in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more capital inflows, than outflows

Capital inflows: $25.4M | Capital outflows: $7.74M

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

14% more funds holding

Funds holding: 83 → 95 (+12)

4.01% more ownership

Funds ownership: 27.38% → 31.4% (+4%)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

30% less call options, than puts

Call options by funds: $6.82M | Put options by funds: $9.8M

Holders
95
Holders Change
+12
Holders Change %
+14.46%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
26
Reduced
30
Closed
12
Calls
$6.82​M
Puts
$9.8​M
Net Calls
-⁠$2.98​M
Net Calls Change
-⁠$4.32​M

CODX Hedge Fund Activity: Q1 2021 in Review

95 of the 5,709 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q1 2021, worth a combined $85.8M — up 19% from $72M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CODX positions and 12 closed out — a net gain of 11 holders — while 26 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.88M. The largest seller was Bank Julius Baer & Co, cutting an estimated $1.3M.

  • 95 institutional investors held Co-Diagnostics (CODX) as of Q1 2021, up from 83 in Q4 2020.
  • Funds reported $85.8M of Co-Diagnostics stock for Q1 2021, up 19% quarter-over-quarter.
  • 23 funds opened new Co-Diagnostics positions in Q1 2021 and 12 closed out, a net change of +11 holders.
  • The largest Co-Diagnostics buyer in Q1 2021 was Vanguard Group, an estimated $2.88M added.
  • The largest Co-Diagnostics seller in Q1 2021 was Bank Julius Baer & Co, an estimated $1.3M sold.

Based on aggregated 13F filings for Q1 2021.